Reliable Individualized Monitoring Improves Cholesterol Control in Kidney Transplant Recipients

Reliable individualized monitoring improves cholesterol control in kidney transplant recipients.

OBJECTIVE To develop and evaluate a system for reliable and efficient individualized risk-based monitoring of cholesterol and 11 other tests after kidney transplantation in children. METHODS We identified system components that drive reliable individualized monitoring and used quality improvement methods to develop and implement interventions, including (1) monitoring schedules individualized...

Immunologic monitoring in kidney transplant recipients

Transplant biopsy has always been the gold standard for assessing the immune response to a kidney allograft (Chandraker A: Diagnostic techniques in the work-up of renal allograft dysfunction-an update. Curr Opin Nephrol Hypertens 8:723-728, 1999). A biopsy is not without risk and is unable to predict rejection and is only diagnostic once rejection has already occurred. However, in the past two ...

Immune monitoring in kidney transplant recipients revisited.

The discovery and clinical implementation of several new immunosuppressant agents along with a variety of advances in clinical care have made a significant impact on the outcome of organ transplantation. Acute rejection rates for renal allograft recipients have fallen precipitously over the last decade, and recently reported data demonstrate prolongation of the halflives of transplanted kidneys...

Diagnostic tools for monitoring kidney transplant recipients.

Recent advancements in immunobiology have introduced several new diagnostic tools for monitoring kidney transplant recipients. These have been added to more established tests that, although imperfect, remain important benchmarks of diagnostic utility. Both new and old tests can be characterized with regard to their practicality, and as to whether they detect aberrant function or define the caus...

Covid-19 infection in kidney transplant recipients: a case report